Paula Anne Newman-Casey, MD, MS

Research Areas

eHealth

Health Services and Epidemiology

• Centers for Diseases Control U01 DP006442-01 “Sustainable community clinic telemedicine-based glaucoma screening”
  To decrease the prevalence of preventable blindness due to glaucoma, we need to: 1) screen high risk people from vulnerable populations, and 2) ensure people with glaucoma from these vulnerable populations receive and adhere to treatment. Community clinics are key resources to utilize for providing glaucoma screening and care coordination. In the Michigan Screening and INtervention for Glaucoma and eye Health through Telemedicine (MI-SIGHT) Progarm, we are leveraging tele-health to provide comprehensive glaucoma screening, education, and follow-up care through the community clinics to provide a sustainable approach to glaucoma care for the vulnerable populations these clinics serve. Website:  https://sightstudies.org/about/university-of-michigan/

Clinical Trials - Glaucoma

• National Eye Institute R01EY031337-01: “Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial”
  To preserve sight, glaucoma patients must take the eye drops recommended by their doctor. And yet, 80% of patients do not consistently take their medications. The Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Program randomized controlled clinical trial will test whether evidence-based individualized education and counseling (https://glaucomaeyeguide.org/demo/learn) alongside personalized reminders improves medication adherence compared to standard care.

Research Summary

Understanding how we can leverage technology to extend the health care system’s reach by helping patients better self-manage their own chronic ophthalmic conditions